| Natural product inhibitors of ocular angiogenesis RS Sulaiman, HD Basavarajappa, TW Corson Experimental eye research 129, 161-171, 2014 | 101 | 2014 |
| Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis PS Shirude, P Madhavapeddi, JA Tucker, K Murugan, V Patil, ... ACS chemical biology 8 (3), 519-523, 2013 | 95 | 2013 |
| Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B MG Kale, A Raichurkar, SH P, D Waterson, D McKinney, MR Manjunatha, ... Journal of medicinal chemistry 56 (21), 8834-8848, 2013 | 70 | 2013 |
| Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization HD Basavarajappa, B Lee, H Lee, RS Sulaiman, H An, C Magaña, ... Journal of Medicinal Chemistry 58 (12), 5015-5027, 2015 | 62 | 2015 |
| The first synthesis of the antiangiogenic homoisoflavanone, cremastranone B Lee, HD Basavarajappa, RS Sulaiman, X Fei, SY Seo, TW Corson Organic & biomolecular chemistry 12 (39), 7673-7677, 2014 | 56 | 2014 |
| Ferrochelatase is a therapeutic target for ocular neovascularization HD Basavarajappa, RS Sulaiman, X Qi, T Shetty, S Sheik Pran Babu, ... EMBO molecular medicine 9 (6), 786-801, 2017 | 51 | 2017 |
| Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy RR Kale, MG Kale, D Waterson, A Raichurkar, SP Hameed, ... Bioorganic & Medicinal Chemistry Letters 24 (3), 870-879, 2014 | 46 | 2014 |
| Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer BL Thériault, HD Basavarajappa, H Lim, S Pajovic, BL Gallie, TW Corson PLoS One 9 (3), e91540, 2014 | 45 | 2014 |
| Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth HD Basavarajappa, B Lee, X Fei, D Lim, B Callaghan, JA Mund, J Case, ... PLoS One 9 (4), e95694, 2014 | 34 | 2014 |
| The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae (sensu APGII) S Schwikkard, H Whitmore, K Sishtla, RS Sulaiman, T Shetty, ... Journal of natural products 82 (5), 1227-1239, 2019 | 24 | 2019 |
| Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids B Lee, W Sun, H Lee, H Basavarajappa, RS Sulaiman, K Sishtla, X Fei, ... Bioorganic & medicinal chemistry letters 26 (17), 4277-4281, 2016 | 24 | 2016 |
| KIF14 As An Oncogene In Retinoblastoma: A Target For Novel Therapeutics? HD Basavarajappa, TW Corson Future medicinal chemistry 4 (17), 2149-2152, 2012 | 22 | 2012 |
| Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase V Humnabadkar, P Madhavapeddi, H Basavarajappa, MG Sheikh, ... Journal of Biomolecular Screening 20 (2), 265-274, 2015 | 6 | 2015 |
| The adaptor protein NumbL is involved in the control of glucolipotoxicity-induced pancreatic beta cell apoptosis HD Basavarajappa, JM Irimia, BM Bauer, PT Fueger International Journal of Molecular Sciences 24 (4), 3308, 2023 | 2 | 2023 |
| Inhibition of ferrochelatase as an antiangiogenic therapy T Corson, H Basavarajappa US Patent 10,752,901, 2020 | 2 | 2020 |
| Griseofulvin inhibits choroidal neovascularization TW Corson, RS Sulaiman, S Alkhairy, K Gupta, HD Basavarajappa Investigative Ophthalmology & Visual Science 57 (12), 2122-2122, 2016 | 2 | 2016 |
| IDENTIFICATION AND CHARACTERIZATION OF A NOVEL SYNTHETIC HOMOISOFLAVONOID AS AN INHIBITOR OF RETINAL ANGIOGENESIS. HD Basavarajappa, B Lee, J Quigley, R Sulaiman, G Rajashekhar, ... Investigative ophthalmology & visual science 55 (13), 1266-1266, 2014 | 2 | 2014 |
| Glucolipotoxic Stress-Induced Mig6 Desensitizes EGFR Signaling and Promotes Pancreatic Beta Cell Death YC Chen, AJ Lutkewitte, HD Basavarajappa, PT Fueger Metabolites 13 (5), 627, 2023 | 1 | 2023 |
| Glucolipotoxicity-induced Mig6 desensitizes EGFR signaling and promotes pancreatic beta cell death YC Chen, AJ Lutkewitte, HD Basavarajappa, PT Fueger bioRxiv, 2020.11. 24.380279, 2020 | 1 | 2020 |
| Compounds for treatment of angiogenesis-mediated diseases TW Corson, HD Basavarajappa, SY Seo, B Lee, X Fei US Patent 10,738,024, 2020 | 1 | 2020 |